Skip to main content
. 2022 Dec 14;27(24):8891. doi: 10.3390/molecules27248891

Table 1.

Summarized information on curcumin analogs.

Compd. Cell Lines Tested
IC50 (µM)
Reference Molecules
IC50 (µM)
Pathway/
Mechanism
Regulation Cell Cycle Arrest
(Phase)
[Ref]
1 MCF-7
13.1 ± 1.6
MCF-7R
12.0 ± 2.0
MCF-7 (CUR)
29.3 ± 1.7
MCF-7R (CUR)
26.2 ± 1.6
NF-κB
STAT3
Bcl-2↓
Bcl-XL
c-IAP-1↓
XIAP↓
NAIP↓
Survivin↓
COX-2↓
S [18]
2 MCF-7
2.56
MDA-MB-231
3.37
MCF-7 (CUR)
21.22
MDA-MB-231 (CUR)
26.9
STAT3 MMP-9↓
MMP-2↓
Mcl-1↓
Cyclin D1↓
c-myc↓
Bcl-XL
Bcl-2↓
Survivin↓
VEGF↓
G1 [19]
3 MCF-7
30
MCF-7 (CUR)
30
NF-κB
P13K/Akt
NF-κB p65↓
c-Rel↓
src↓
COX-2↓
MMP-9↓
TIMP-2↑
VEGF↓
TNFα↓
IL-1β↓
TGF-β↓
IL-8↓
NA [21]
4 NA NA HER2
P13K/Akt
ERK1/2
NA G2/M [22]
5 MCF-7
18
MCF-7 (Tamoxifen)
4
HER2 Cyclin D1↓
Survivin↓
Bcl-2↓
CDC2↓
NA [23]
6j MCF-7
15
NA NA Bcl-2↓ NA [24]
7i MCF-7
10
NA NA Bcl-2↓ NA [24]
8a MCF-7
20 *
MCF-7 (DOX)
13
NA NA G2/M [25]
9 SKBR3
1.71 ± 0.10
MDA-MB-231
4.49 ± 0.46
MCF-7
9.09 ± 0.46
MDA-MB-453
10.42 ± 0.92
SKBR3 (Cisplatin)
3.04 ± 0.17
MDA-MB-231 (Cisplatin)
12.81 ± 0.58
MCF-7 (Cisplatin)
11.16 ± 0.60
MDA-MB-453 (Cisplatin)
15.43 ± 0.83
NA NA NA [26]
10 MCF-7
8.84
MDA-MB-231
8.31
MCF-7 (CUR)
16.85
MDA-MB-231 (CUR)
42.01
NA p21↑
Cyclin D1↓
CDK2↓
Bax↑
Cyto-C↑
Bcl-2↓
VEGF↓
TIMP1↑
TIMP2↑
G1 [27]
12b MDA-MB-231
4.99 ± 1.02
MDA-MB-231 (Cisplatin)
6.18 ± 0.79
NA NA NA [29]
13 MCF-7
0.317
MDA-MB-231
0.473
HS 578T
0.295
BT-549
0.693
T-47D
0.79
MDA-MB-468
0.248
NA EGFR NA NA [30]
14 MCF-7
0.162
MDA-MB-231
0.404
HS 578T
0.0779
BT-549
0.631
T-47D
0.793
MDA-MB-468
0.276
NA EGFR NA NA [30]
15 MCF-7
1.81
MDA-MB-231
1.45
HS 578T
0.524
BT-549
1.3
T-47D
2.83
NA EGFR NA NA [30]
16 MCF-7
2.7 ± 0.5
MDA-MB-231
1.5 ± 0.1
MCF-7 (CUR)
21.5 ± 4.7
MDA-MB-231 (CUR)
25.6 ± 4.8
NA NA NA [31]
17 MCF-7
0.4 ± 0.1MDA-MB-231
0.6 ± 0.1
MCF-7 (CUR)
21.5 ± 4.7
MDA-MB-231 (CUR)
25.6 ± 4.8
NA NA NA [31]
18 MCF-7
2.4 ± 1.0
MDA-MB-231
2.4 ± 0.4
MCF-7 (CUR)
21.5 ± 4.7
MDA-MB-231 (CUR)
25.6 ± 4.8
NA NA NA [31]
19b MCF-7
1.97 **
MDA-MB-231
3.06 **
HS 578T
5.10 **
BT-549
1.96 **
T-47D
2.81 **
MDA-MB-468
2.30 **
NA EGFR NA NA [32]

* µg/mL, ** GI50.